Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2010
09/22/2010EP1692114B1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
09/22/2010EP1618092B1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/22/2010CN1788001B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
09/22/2010CN101842368A Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
09/22/2010CN101842361A Pyrazinone derivatives and their use in the treatment of lung diseases
09/22/2010CN101842360A Anti-infective pyrimidines and uses thereof
09/22/2010CN101838271A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
09/22/2010CN101837302A Method for preparing chiral imidazolinone ionic liquid catalyst
09/22/2010CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases
09/21/2010US7799928 Process for the preparation of irbesartan hydrochloride
09/21/2010US7799915 Several exemplified (pyrimidin-2-ylamino)benzenesulfonamide compounds such as N-phenyl-4-[(4-thien-2-ylpyrimidin-2-yl)amino]benzenesulfonamide; I kappa B kinase inhibitors (IKK inhibitors); anticancer agents, autoimmune diseases, osteoporosis
09/21/2010US7799782 P38 inhibitors and methods of use thereof
09/21/2010US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans
09/21/2010CA2521492C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
09/21/2010CA2481229C Substituted pyrazine inhibitors of akt
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2359948C Triazole compounds with dopamine-d3-receptor affinity
09/16/2010WO2010104933A1 Inhibitors of akt activity
09/16/2010WO2010104843A2 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors
09/16/2010WO2010104406A1 Prodrug forms of kinase inhibitors and their use in therapy
09/16/2010WO2010104349A2 Compounds usable as materials for a hole injection layer or hole transport layer, and organic light-emitting diode using same
09/16/2010WO2010104093A1 Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010103684A1 Sequence-specific expression regulator which targets at myc downstream gene, and method for determining target or targets of myc downstream gene
09/16/2010WO2010103683A1 Topical therapeutic agent for ophthalmic diseases comprising compound capable of binding specifically to dna sequence
09/16/2010WO2010103438A1 Substituted indazole amides and their use as glucokinase activators
09/16/2010WO2010103334A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103333A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103306A1 Benzimidazole derivatives and their use as antivaral agents
09/16/2010WO2010081835A3 Bis-resorcinyl-triazine derivatives as protecting agents against uv radiation
09/16/2010WO2010077836A3 Pyrrolidine compounds which modulate the cb2 receptor
09/16/2010WO2010065110A3 Antimicrobials
09/16/2010WO2010062686A3 Imidazol-4-one and imidazole-4-thione compounds
09/16/2010WO2010057118A3 Heterocyclic antagonists of prostaglandin d2 receptors
09/16/2010WO2010056847A3 Lyophilization formulation
09/16/2010WO2010056320A3 Pi3k/mtor kinase inhibitors
09/16/2010WO2010053583A3 Small molecule cd4 mimetics and uses thereof
09/16/2010US20100234615 Process for the synthesis of triazoles
09/16/2010US20100234591 Biaryl heterocyclic compounds and methods of making and using the same
09/16/2010US20100234431 Pyrrolidine compounds
09/16/2010US20100234425 2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
09/16/2010US20100234424 Derivatives of n-phenyl(piperidine-2-yl) methyl benzamide preparation method thereof and applications of same in therapeutics
09/16/2010US20100234422 Sulfonylated Heterocycles Useful for Modulation of the Progesterone Receptor
09/16/2010US20100234405 Pyrimidine nucleoside derivatives and salts thereof
09/16/2010US20100234391 N-substituted piperazines
09/16/2010US20100234389 Amide compound
09/16/2010US20100234380 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
09/16/2010US20100234378 Alkylsulfonamide-substituted triazoles as matrix metalloprotease inhibitors
09/16/2010US20100234377 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
09/16/2010US20100234376 [4,5']Bipyrimidinyl-6,4'-Diamine Deriviatives as Protein Kinase Inhibitors
09/16/2010US20100234374 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors
09/16/2010US20100234356 Compounds useful as chemokine receptor antagonists
09/16/2010US20100234354 Pyridazinone derivatives
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234341 Substituted pyrimidines as adenosine receptor antagonists
09/16/2010US20100234285 Benzofuranyl Derivatives
09/16/2010US20100233190 Targeted polymeric prodrugs containing multifunctional linkers
09/16/2010US20100233166 Novel ido inhibitors and methods of use
09/16/2010US20100233122 Novel benzimidazole derivatives
09/16/2010US20100233120 Hepatitis C Virus Inhibitors
09/16/2010US20100233106 Small-molecule modulators of melanin expression
09/16/2010CA2755118A1 Preventive or therapeutic agents for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivatives or salts thereof as active ingredients
09/16/2010CA2754808A1 Prodrug forms of kinase inhibitors and their use in therapy
09/16/2010CA2754791A1 Compounds for the treatment of metabolic disorders
09/16/2010CA2754709A1 Compounds for the treatment of metabolic disorders
09/16/2010CA2754685A1 Substituted indazole amides
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010CA2754180A1 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2227770A2 Prolyl hydroxylase inhibitors
09/15/2010EP2227464A1 Derivatives of 1-[(imidazolidin-2-yl)imino)]indazole
09/15/2010EP2227461A1 New compounds iii
09/15/2010EP2227460A1 Therapeutic oxy-phenyl-aryl compounds and their use
09/15/2010EP2227456A2 Hedgehog pathway antagonists and therapeutic applications thereof
09/15/2010EP1910314B1 Benzimidazole derivatives for treatment of inflammatory diseases
09/15/2010CN101835774A Co-crystals and pharmaceutical compositions comprising the same
09/15/2010CN101835760A Arylindenopyrimidines and their use as adenosine A2a receptor antagonists
09/15/2010CN101835755A Novel kinase inhibitors
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101830853A Nitroimidazoline derivatives and preparation method thereof and application thereof
09/14/2010US7795447 4-(Acylaminoacetylamino)imidazole derivatives, e.g., methyl 3-(4-{2-[2-(3,5-Difluorophenyl)acetylamino]pentanoylamino}imidazol-1-yl)butyrate; treating neurodegenerative and/or neurological disorders such as Alzheimer's disease and Down's Syndrome
09/14/2010US7795440 N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders
09/14/2010US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
09/14/2010US7795280 3-(2-Nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indole-6-carbonitrile, used for the treatment of benign prostate hyperplasia, bone disorders, female sexual dysfunction,, atherosclerosis, anemia, muscular atrophy, as contraceptives or for hormone replacement therapy
09/14/2010US7795276 Imiadazo[4,5-c] pyridine compound and method of antiviral treatment
09/14/2010US7795271 Substituted pyrimidinones
09/14/2010US7795266 Tetrahydroindolone derivatives for treament of neurological conditions
09/14/2010US7795265 such as 3-(4-{[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl}-1-piperazinyl)-1-naphthoic acid, used for the treatment of obesity or diabetes
09/14/2010US7795255 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents
09/14/2010US7795250 Indole derivatives as antiviral agents
09/14/2010US7794748 Stable oral solid drug composition
09/14/2010CA2441501C Rho-kinase inhibitors
09/14/2010CA2394276C Serine protease inhibitors
09/14/2010CA2393720C Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
09/14/2010CA2354210C Indole derivatives and their use as medicaments
09/10/2010WO2010102212A2 Neurotrophin mimetics and uses thereof
09/10/2010WO2010101973A1 Fungicidal pyrazoles
09/10/2010WO2010101849A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
09/10/2010WO2010101298A1 Fluorescent mri probe
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 626